Literature DB >> 28003378

Chronic Type I IFN Is Sufficient To Promote Immunosuppression through Accumulation of Myeloid-Derived Suppressor Cells.

Kahina Taleb1,2,3, Cédric Auffray1,2,3, Pascale Villefroy1,2,3, Adrien Pereira1,2,3, Anne Hosmalin1,2,3, Muriel Gaudry1,2,3, Agnès Le Bon4,5,6.   

Abstract

Failure of the immune system to eradicate viruses results in chronic viral infections, which are associated with increased susceptibility to secondary infections. Pathogenic HIV or lymphocytic choriomeningitis virus chronic infections display a persistent type I IFN signature. In chronic lymphocytic choriomeningitis virus infection, blockade of type I IFN signaling partially restores antiviral responses. In a mouse model, we tested whether chronic administration of type I IFN, at doses mimicking chronic viral infection, induced immunosuppression. Chronic exposure of mice to IFN-α alone was sufficient to strongly suppress specific CD8+ T cells responses to subsequent vaccinia virus infection. It resulted in the accumulation of Ly6Chi monocytes. These monocytes were similar, phenotypically and functionally, to the myeloid-derived suppressor cells found in cancer because they exerted a potent suppression on CD8+ T cell responses in vitro. They acted at least partly through the l-arginine pathway. In vivo, their elimination restored antiviral CD8+ T cell responses. Our work provides a specific mechanism accounting for the role of IFN-α in immunosuppression and predicts that type I IFN modulation will be pivotal to cure human chronic infections, cancer, or autoimmune diseases.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28003378     DOI: 10.4049/jimmunol.1502638

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

Review 1.  Crosstalk between type I and II interferons in regulation of myeloid cell responses during bacterial infection.

Authors:  William J Crisler; Laurel L Lenz
Journal:  Curr Opin Immunol       Date:  2018-06-07       Impact factor: 7.486

2.  STING signaling remodels the tumor microenvironment by antagonizing myeloid-derived suppressor cell expansion.

Authors:  Chuan-Xia Zhang; Shu-Biao Ye; Jian-Jiao Ni; Ting-Ting Cai; Yi-Na Liu; Dai-Jia Huang; Hai-Qiang Mai; Qiu-Yan Chen; Jia He; Xiao-Shi Zhang; Yi-Xin Zeng; Jiang Li; Jun Cui
Journal:  Cell Death Differ       Date:  2019-02-28       Impact factor: 15.828

3.  Entecavir and Peginterferon Alfa-2a in Adults With Hepatitis B e Antigen-Positive Immune-Tolerant Chronic Hepatitis B Virus Infection.

Authors:  Jordan J Feld; Norah A Terrault; Hsing-Hua S Lin; Steven H Belle; Raymond T Chung; Naoky Tsai; Mandana Khalili; Robert Perrillo; Stewart L Cooper; Marc G Ghany; Harry L A Janssen; Anna S Lok
Journal:  Hepatology       Date:  2019-03-14       Impact factor: 17.425

Review 4.  Animal Models for the Study of Nucleic Acid Immunity: Novel Tools and New Perspectives.

Authors:  Isabelle K Vila; Maxence Fretaud; Dimitrios Vlachakis; Nadine Laguette; Christelle Langevin
Journal:  J Mol Biol       Date:  2020-08-26       Impact factor: 5.469

Review 5.  Resistance to Immune Checkpoint Inhibitors Secondary to Myeloid-Derived Suppressor Cells: A New Therapeutic Targeting of Haematological Malignancies.

Authors:  Alejandro Olivares-Hernández; Luis Figuero-Pérez; Eduardo Terán-Brage; Álvaro López-Gutiérrez; Álvaro Tamayo Velasco; Rogelio González Sarmiento; Juan Jesús Cruz-Hernández; José Pablo Miramontes-González
Journal:  J Clin Med       Date:  2021-04-28       Impact factor: 4.241

6.  TANK-Binding Kinase 1 (TBK1) Serves as a Potential Target for Hepatocellular Carcinoma by Enhancing Tumor Immune Infiltration.

Authors:  Yuchuan Jiang; Siliang Chen; Qiang Li; Junjie Liang; Weida Lin; Jinying Li; Zhilong Liu; Mingbo Wen; Mingrong Cao; Jian Hong
Journal:  Front Immunol       Date:  2021-02-18       Impact factor: 7.561

Review 7.  Sustained IFN-I Expression during Established Persistent Viral Infection: A "Bad Seed" for Protective Immunity.

Authors:  Xavier Dagenais-Lussier; Hamza Loucif; Armstrong Murira; Xavier Laulhé; Simona Stäger; Alain Lamarre; Julien van Grevenynghe
Journal:  Viruses       Date:  2017-12-30       Impact factor: 5.048

Review 8.  Human Immunodeficiency Virus 1 and Type I Interferons-Where Sex Makes a Difference.

Authors:  Susanne Maria Ziegler; Marcus Altfeld
Journal:  Front Immunol       Date:  2017-09-28       Impact factor: 7.561

9.  Effect of age on chronic inflammation and responsiveness to bacterial and viral challenges.

Authors:  Ingrid Elisia; Vivian Lam; Elyse Hofs; Michael Yu Li; Mariah Hay; Brandon Cho; Angela Brooks-Wilson; Miriam Rosin; Luke Bu; William Jia; Gerald Krystal
Journal:  PLoS One       Date:  2017-11-29       Impact factor: 3.240

Review 10.  The role of myeloid-derived suppressor cells in hematologic malignancies.

Authors:  Emine Gulsen Gunes; Steven T Rosen; Christiane Querfeld
Journal:  Curr Opin Oncol       Date:  2020-09       Impact factor: 3.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.